A new radioimmunotherapy approach has been shown to successfully eliminate cancer stem cells (CSCs) in preclinical models of ovarian cancer, outperforming the current gold standard. This research, ...
Cancer stem cells (CSCs) represent a distinct subpopulation within tumours, characterised by their capacity for self‐renewal and differentiation. These cells are pivotal in driving tumour growth, ...
New radioimmunotherapy approach eliminates cancer stem cells in preclinical models of ovarian cancer
A new radioimmunotherapy approach has been shown to successfully eliminate cancer stem cells (CSCs) in preclinical models of ovarian cancer, outperforming the current gold standard. This research, ...
Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based ...
A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer ...
Schematic showing IL-6-induced STAT3-to-PI3K signaling switch in colorectal cancer stem cells, driving ZEB1-dependent PD-L1 expression and immune evasion. A landmark study published in Science ...
In a first-of-its-kind clinical trial, UCLA scientists have shown it's possible to reprogram a patient's blood-forming stem cells to generate a continuous supply of functional T cells, the immune ...
Researchers have unlocked a way to grow the immune system’s “conductors” from stem cells, bringing ready-made cancer-fighting therapies a big step closer. For the first time, scientists at the Univers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback